Skip to content

MEDPASYL

Active Private limited companyfounded 2005active for 21 yearsRue de Beaulieu 60, 7021 MonsKBO/BCE: BE 0873.149.458

Lifetime

20 annual accounts with figures on one time axis, 21 filings since 2005
peak of €81,691 in 2017
€81,182▲ 244%
lowest -€8,719 in 2024
€58,397▲ €67,116
peak of €346,190 in 2025
€346,190▲ 20.3%
€27,029▼ 61.2%
Board2 names since 2011
2 directors and 1 other
Owners2 names in the annual accounts
  
Documentsfilings and deeds
04-08-20264 days late
2025micro format
Gross margin from €23,614 to €81,182Profit of €58,397, after a lossEquity from €287,793 to €346,190Debts from €69,741 to €27,029Cash from €17,073 to €257,671

Key points

from the 2025 annual accounts

Result

€58,397 €58,397
-€8,7202024€58,4002025

Back in profit in 2025, after a loss of €8,719 in 2024.

Liquidity

13.81 was 6.36 in 2024

Short-term debts fell from €37,924 to €27,029.

Filings

21 annual accounts since 2005
AprilJune31 JulyOctober20052010201520202025

Ten of the last ten came late. The 2019 accounts came in latest, 92 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as MEDPASYL has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for MEDPASYL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • annual accounts 2017
  • annual accounts 2017
Board & ownership

Recent changes

2 managers resigning, 2 directors reappointed (manager) and (manager) resign · (director) and (director) reappointed · holds 93 shares · Gazette deed
(gérants non statutaires) and (gérants non statutaires) reappointed General meeting of 10-03-2017 · Gazette deed
(manager) and (manager) appointed General meeting of 18-02-2013 · Gazette deed
Incorporation published on 21-04-2005 · Gazette deed
All 34 events

Comparable companies

same main activity, similar in size and age
Company
MEDPASYL Mons €373,219 €81,182 92.8% -
CARDO Tournai €360,276 €86,070 43.1% -
DR.COENYE EMERGENCY & SURGERY Lasne €367,328 €80,652 58.3% -
DOKTER MARIES AERTGEERTS Tremelo €358,787 €87,287 67.0% -
FOUREZ - MEYNCKENS Etterbeek €340,085 €77,398 97.1% -
Dr. Van Ballaer Meerhout €422,324 €78,276 91.1% -
DOCTEUR NICOLAS BERG Liège €422,669 €78,285 92.6% -

These companies have the same main activity as MEDPASYL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €340,000 and €423,000, founded between 2003 and 2005.

Official details

Source: KBO
Status
Active since 13-04-2005Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €180,000estimated
€373,219▲ 4.4%
Filing
Filed on 04-08-2026
Financials

Insights on MEDPASYL

MEDPASYL files the micro format. That format states no turnover. The gross margin rose from €52,737 in 2006 to €81,182 in 2025.

The balance sheet grew most from 2012 to 2014 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDPASYL

What is the company number of MEDPASYL?
The company number of MEDPASYL is 0873.149.458. The VAT number is the same number with BE in front: BE 0873.149.458.
Where is MEDPASYL based?
The registered office is at Rue de Beaulieu 60, 7021 Mons.Company details
What does MEDPASYL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MEDPASYL?
MEDPASYL is a private limited company (BV).
When was MEDPASYL founded?
MEDPASYL was founded on 13-04-2005.
Is MEDPASYL still active?
Yes, MEDPASYL is an active enterprise in the KBO register.
What is the turnover of MEDPASYL?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €81,182 and 33 comparable companies (NACE 862). It probably lies between €140,000 and €230,000.Financials
Is MEDPASYL profitable?
In financial year 2025, MEDPASYL made a profit of €58,397.
Where can I find the annual accounts of MEDPASYL?
MEDPASYL filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDPASYL due?
MEDPASYL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.